Inventor · disambiguated record
Kurt Van Vloten
Also filed as: VAN VLOTEN KURT · VAN VLOTEN KURT D
3 granted patents·7 pending applications·4 citations·filing 2009–2024
59Inventor score
Files withBIOGEN MA INC3SUNESIS PHARMACEUTICALS INC3VIRACTA THERAPEUTICS INC2ARNDT JOSEPH1CHUAQUI CLAUDIO1
Top patents by PatentIndex Score
10 records- 0184US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0280US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 0377US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0470US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 0570US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0663US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0760US2025304577A1Tyk2 inhibitorsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 0858US2021340107A1Nrf2 activatorBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 0952US10968181B2NRF2 activatorBIOGEN MA INC·Filed 2017·Granted Apr 6, 2021·0 cites·24 claims
- 1050US2012040951A1Heteroaryl compounds useful as raf kinase inhibitorsCHUAQUI CLAUDIO·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kurt Van Vloten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →